{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T23:41:56Z","timestamp":1790379716721,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100020320","name":"IReSP","doi-asserted-by":"publisher","award":["IRESP-19-ADDICTIONS-07"],"award-info":[{"award-number":["IRESP-19-ADDICTIONS-07"]}],"id":[{"id":"10.13039\/501100020320","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jsatjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Use and Addiction Treatment"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.josat.2023.209182","type":"journal-article","created":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T04:15:43Z","timestamp":1697602543000},"page":"209182","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Barriers and facilitators to the involvement of general practitioners in the prescription of buprenorphine"],"prefix":"10.1016","volume":"156","author":[{"given":"La\u00ebtitia","family":"Gimenez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00e9lia","family":"Bonis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathilde","family":"Morel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurore","family":"Palmaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lise","family":"Dassieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Dupouy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1016\/j.josat.2023.209182_bb0005","first-page":"S17","article-title":"French field experience with buprenorphine","volume":"13","author":"Auriacombe","year":"2004","journal-title":"The American Journal on Addictions"},{"key":"10.1016\/j.josat.2023.209182_bb0010","article-title":"Treatment and care of opioid users by general practitioners: Current situation and trends","volume":"3","author":"Beck","year":"2013","journal-title":"Revue francaise des affaires sociales"},{"key":"10.1016\/j.josat.2023.209182_bb0015","article-title":"Les niveaux d\u2019usage des drogues illicites en France en 2014","volume":"99","author":"Beck","year":"2015","journal-title":"Tendances"},{"issue":"1\u20132","key":"10.1016\/j.josat.2023.209182_bb0020","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.drugalcdep.2009.03.020","article-title":"Comparing overdose mortality associated with methadone and buprenorphine treatment","volume":"104","author":"Bell","year":"2009","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.josat.2023.209182_bb0025","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2147\/IJGM.S61014","article-title":"The current status of opioid maintenance treatment in France: A survey of physicians, patients, and out-of-treatment opioid users","volume":"7","author":"Benyamina","year":"2014","journal-title":"International Journal of General Medicine"},{"issue":"11","key":"10.1016\/j.josat.2023.209182_bb0030","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1111\/medu.13182","article-title":"Revising residents\u2019 addiction experience: A 1-week intensive course","volume":"50","author":"Bhatraju","year":"2016","journal-title":"Medical Education"},{"key":"10.1016\/j.josat.2023.209182_bb0035","series-title":"Handbook of research methods in health social sciences","first-page":"843","article-title":"Thematic analysis","author":"Braun","year":"2019"},{"key":"10.1016\/j.josat.2023.209182_bb0040","author":"Brisacier"},{"issue":"2","key":"10.1016\/j.josat.2023.209182_bb0045","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s12152-020-09440-w","article-title":"Determinism and destigmatization: Mitigating blame for addiction","volume":"14","author":"Clark","year":"2021","journal-title":"Neuroethics"},{"issue":"1","key":"10.1016\/j.josat.2023.209182_bb0050","doi-asserted-by":"crossref","DOI":"10.3917\/ccgc.006.0179","article-title":"La s\u00e9lection entre logique d\u2019appropriation et stigmatisation. Les m\u00e9decins g\u00e9n\u00e9ralistes face aux patients d\u00e9pendants aux opiac\u00e9s","volume":"6","author":"Dassieu","year":"2014","journal-title":"Les Cahiers du Centre Georges Canguilhem"},{"key":"10.1016\/j.josat.2023.209182_bb0055","series-title":"Opiate substitution treatments in general practice: The appropriations of a public policy","author":"Dassieu","year":"2015"},{"key":"10.1016\/j.josat.2023.209182_bb0060","article-title":"L\u2019autom\u00e9dication chez les usagers de drogues: De la constitution de savoirs exp\u00e9rientiels \u00e0 leur confrontation aux m\u00e9decins","volume":"18","author":"Dassieu","year":"2019","journal-title":"Anthropologie & Sant\u00e9. Revue internationale francophone d\u2019anthropologie de la sant\u00e9"},{"key":"10.1016\/j.josat.2023.209182_bb0065","first-page":"47","article-title":"Les m\u00e9decins g\u00e9n\u00e9ralistes face aux conduites addictives de leurs patients","volume":"80","author":"David","year":"2021","journal-title":"Les dossiers de la DREES"},{"issue":"424","key":"10.1016\/j.josat.2023.209182_bb0070","article-title":"The general practitioner, the drug misuser, and the alcohol misuser: Major differences in general practitioner activity, therapeutic commitment, and \u201cshared care\u201d proposals","volume":"47","author":"Deehan","year":"1997","journal-title":"The British Journal of General Practice"},{"key":"10.1016\/j.josat.2023.209182_bb0075","first-page":"3019","article-title":"Analysis of barriers to adoption of buprenorphine maintenance therapy by family physicians","volume":"15","author":"DeFlavio","year":"2015","journal-title":"Rural and Remote Health"},{"key":"10.1016\/j.josat.2023.209182_bb0080","series-title":"Grounding grounded theory: Guidelines for qualitative inquiry","author":"Dey","year":"1999"},{"issue":"6","key":"10.1016\/j.josat.2023.209182_bb0085","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1159\/000506630","article-title":"Primary care of opioid use disorder: The end of \u201cthe French Model\u201d?","volume":"26","author":"Dupouy","year":"2020","journal-title":"European Addiction Research"},{"issue":"4","key":"10.1016\/j.josat.2023.209182_bb0090","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1370\/afm.2098","article-title":"Mortality associated with time in and out of buprenorphine treatment in French office-based general practice: A 7-year cohort study","volume":"15","author":"Dupouy","year":"2017","journal-title":"Annals of Family Medicine"},{"issue":"1","key":"10.1016\/j.josat.2023.209182_bb0095","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1080\/13814788.2018.1470239","article-title":"Intensity of previous teaching but not diagnostic skills influences stigmatization of patients with substance use disorder by general practice residents. A vignette study among French final-year residents in general practice","volume":"24","author":"Dupouy","year":"2018","journal-title":"The European Journal of General Practice"},{"key":"10.1016\/j.josat.2023.209182_bb0100","author":"European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)"},{"issue":"5","key":"10.1016\/j.josat.2023.209182_bb0105","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/s11920-007-0046-2","article-title":"Why buprenorphine is so successful in treating opiate addiction in France","volume":"9","author":"Fatseas","year":"2007","journal-title":"Current Psychiatry Reports"},{"issue":"1","key":"10.1016\/j.josat.2023.209182_bb0110","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.addbeh.2004.04.019","article-title":"French general practitioners\u2019 prescribing high-dosage buprenorphine maintenance treatment: Is the existing training (good) enough?","volume":"30","author":"Feroni","year":"2005","journal-title":"Addictive Behaviors"},{"issue":"5","key":"10.1016\/j.josat.2023.209182_bb0115","doi-asserted-by":"crossref","DOI":"10.1097\/01.mlr.0000160418.72625.1c","article-title":"Physician and patient gender concordance and the delivery of comprehensive clinical preventive services","volume":"43","author":"Flocke","year":"2005","journal-title":"Medical Care"},{"issue":"2","key":"10.1016\/j.josat.2023.209182_bb0120","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.0217","article-title":"The burden of opioid-related mortality in the United States","volume":"1","author":"Gomes","year":"2018","journal-title":"JAMA Network Open"},{"key":"10.1016\/j.josat.2023.209182_bb0125","series-title":"Les microstructures m\u00e9dicales: \u00c9volutions \u00e0 24 mois des scores du questionnaire ASI","author":"Hedelin","year":"2004"},{"key":"10.1016\/j.josat.2023.209182_bb0130","author":"Institut national de pr\u00e9vention et d'\u2019\u00e9ducation pour la sant\u00e9 (INPES)"},{"issue":"2","key":"10.1016\/j.josat.2023.209182_bb0135","first-page":"23","article-title":"Representation of opiate substitution treatment and their stop. Viewpoints of patients\/doctors","volume":"19","author":"Landreat","year":"2013","journal-title":"Psychotropes"},{"issue":"4","key":"10.1016\/j.josat.2023.209182_bb0140","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.therap.2020.06.006","article-title":"Addictovigilance contribution during COVID-19 epidemic and lockdown in France","volume":"75","author":"Lapeyre-Mestre","year":"2020","journal-title":"Therapie"},{"key":"10.1016\/j.josat.2023.209182_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2022.108891","article-title":"Prescribing buprenorphine for opioid use disorder in primary care: A survey of French general practitioners in the Sentinelles network","volume":"143","author":"L\u00e9pine","year":"2022","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2023.209182_bb0150","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.drugpo.2019.10.005","article-title":"Ambiguous identities of drugs and people: A scoping review of opioid-related stigma","volume":"74","author":"McCradden","year":"2019","journal-title":"The International Journal on Drug Policy"},{"key":"10.1016\/j.josat.2023.209182_bb0155","author":"Monzon"},{"issue":"2\u20133","key":"10.1016\/j.josat.2023.209182_bb0160","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.healthpol.2010.06.001","article-title":"Effect of a French experiment of team work between general practitioners and nurses on efficacy and cost of type 2 diabetes patients care","volume":"98","author":"Mousqu\u00e8s","year":"2010","journal-title":"Health Policy"},{"issue":"1","key":"10.1016\/j.josat.2023.209182_bb0165","first-page":"89","article-title":"Doctor shopping reveals geographical variations in opioid abuse","volume":"16","author":"Nordmann","year":"2013","journal-title":"Pain Physician"},{"key":"10.1016\/j.josat.2023.209182_bb0170","article-title":"\u00c9volution de la prise en charge des toxicomanes: Enqu\u00eate aupr\u00e8s des m\u00e9decins g\u00e9n\u00e9ralistes en 2001 et comparaison 92-95-98-2001","volume":"20","author":"Observatoire europ\u00e9en des drogues et des toxicomanies (OFDT)","year":"2002","journal-title":"Tendances"},{"key":"10.1016\/j.josat.2023.209182_bb0175","article-title":"Perceptions et opinions des Fran\u00e7ais sur les drogues","volume":"88","author":"Observatoire europ\u00e9en des drogues et des toxicomanies (OFDT)","year":"2013","journal-title":"Tendances"},{"key":"10.1016\/j.josat.2023.209182_bb0180","author":"Observatoire europ\u00e9en des drogues et des toxicomanies (OFDT)"},{"key":"10.1016\/j.josat.2023.209182_bb0185","article-title":"Les personnes accueillies dans les CSAPA: situation en 2019 et \u00e9volution 2015-2019","volume":"146","author":"Palle","year":"2019","journal-title":"Tendances"},{"key":"10.1016\/j.josat.2023.209182_bb0190","author":"Pariente"},{"issue":"156","key":"10.1016\/j.josat.2023.209182_bb0195","doi-asserted-by":"crossref","first-page":"340","DOI":"10.56746\/EXERCER.2019.156.340","article-title":"Rep\u00e9rage des troubles li\u00e9s \u00e0 une substance et troubles addictifs en soins premiers","volume":"2019","author":"Pautrat","year":"2019","journal-title":"Exercer"},{"key":"10.1016\/j.josat.2023.209182_bb0200","series-title":"Les traitements de substitution en Belgique. D\u00e9veloppement d\u2019un mod\u00e8le d\u2019\u00e9valuation des diverses fili\u00e8res de soins et de patients","first-page":"189","author":"Perc","year":"2005"},{"key":"10.1016\/j.josat.2023.209182_bb0205","series-title":"La Recherche Qualitative. Enjeux \u00c9pist\u00e9mologiques et M\u00e9thodologiques","first-page":"113","article-title":"\u00c9chantillonnage et recherche qualitative: Essai th\u00e9orique et m\u00e9thodologique","author":"Pires","year":"1997"},{"key":"10.1016\/j.josat.2023.209182_bb0210","isbn-type":"print","article-title":"Qualitative Research in Health Care 3e","year":"2006","ISBN":"https:\/\/id.crossref.org\/isbn\/9781405135122"},{"issue":"9","key":"10.1016\/j.josat.2023.209182_bb0215","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1037\/0003-066X.47.9.1102","article-title":"In search of how people change. Applications to addictive behaviors","volume":"47","author":"Prochaska","year":"1992","journal-title":"The American Psychologist"},{"issue":"2","key":"10.1016\/j.josat.2023.209182_bb0220","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1080\/09595230500102434","article-title":"Stigma, social inequality and alcohol and drug use","volume":"24","author":"Room","year":"2005","journal-title":"Drug and Alcohol Review"},{"key":"10.1016\/j.josat.2023.209182_bb0225","series-title":"M\u00e9thodes de recherche en management","article-title":"Chapitre 8: \u00c9chantillon(s)","author":"Royer","year":"2014"},{"issue":"9","key":"10.1016\/j.josat.2023.209182_bb0230","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1001\/jamapsychiatry.2021.0976","article-title":"Association of opioid agonist treatment with all-cause mortality and specific causes of death among people with opioid dependence: A systematic review and meta-analysis","volume":"78","author":"Santo","year":"2021","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.josat.2023.209182_bb0235","series-title":"Singuliers g\u00e9n\u00e9ralistes","article-title":"\u201cQui mieux que nous?\u201d Les ambivalences du \u201cg\u00e9n\u00e9raliste-pivot\u201d du syst\u00e8me de soins","author":"Sarradon-Eck","year":"2010"},{"issue":"5","key":"10.1016\/j.josat.2023.209182_bb0240","doi-asserted-by":"crossref","DOI":"10.2105\/AJPH.2012.301049","article-title":"Opioid agonist treatments and heroin overdose deaths in Baltimore, Maryland, 1995\u20132009","volume":"103","author":"Schwartz","year":"2013","journal-title":"American Journal of Public Health"},{"key":"10.1016\/j.josat.2023.209182_bb0245","article-title":"Mortality risk during and after opioid substitution treatment: Systematic review and meta-analysis of cohort studies","volume":"357","author":"Sordo","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.josat.2023.209182_bb0250","article-title":"Drogues: Perceptions des produits, des politiques publiques et des usagers","volume":"131","author":"Spilka","year":"2019","journal-title":"Tendances"},{"issue":"37","key":"10.1016\/j.josat.2023.209182_bb0255","doi-asserted-by":"crossref","first-page":"44","DOI":"10.7748\/ns.29.37.44.e8822","article-title":"Focus group research","volume":"29","author":"Traynor","year":"2015","journal-title":"Nursing Standard (Royal College of Nursing (Great Britain): 1987)"},{"issue":"1","key":"10.1016\/j.josat.2023.209182_bb0260","doi-asserted-by":"crossref","DOI":"10.2174\/187447370801150611184218","article-title":"The misuse of prescription opioids: A threat for Europe?","volume":"8","author":"Van Amsterdam","year":"2015","journal-title":"Current Drug Abuse Reviews"},{"issue":"4","key":"10.1016\/j.josat.2023.209182_bb0265","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1056\/NEJMra1511480","article-title":"Neurobiologic advances from the brain disease model of addiction","volume":"374","author":"Volkow","year":"2016","journal-title":"The New England Journal of Medicine"},{"issue":"3","key":"10.1016\/j.josat.2023.209182_bb0270","first-page":"256","article-title":"Focus group discussion: A tool for health and medical research","volume":"49","author":"Wong","year":"2008","journal-title":"Singapore Medical Journal"}],"container-title":["Journal of Substance Use and Addiction Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875923002333?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875923002333?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T01:39:54Z","timestamp":1762652394000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949875923002333"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":54,"alternative-id":["S2949875923002333"],"URL":"https:\/\/doi.org\/10.1016\/j.josat.2023.209182","relation":{},"ISSN":["2949-8759"],"issn-type":[{"value":"2949-8759","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Barriers and facilitators to the involvement of general practitioners in the prescription of buprenorphine","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Use and Addiction Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.josat.2023.209182","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"209182"}}